Formation of high-molecular-weight angiotensinogen during pregnancy, is a result of competing redox reactions with the proform of eosinophil major basic protein

Biochemical Journal

Volumn 449, Issue 1, 2013, Pages 209-217

  Kløverpris, Søren ^a   Skov, Louise L ^a   Glerup, Simon ^a   Pihl, Kasper ^b   Christiansen, Michael ^b   Oxvig, Claus ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Angiotensinogen (AGT); Disulfide linked complexes; Pregnancy; Pregnancy associated plasma protein A (PAPP A); Proform of eosinophil major basic protein (proMBP); Renin substrate

Indexed keywords

ANGIOTENSINOGEN; COMPLEMENT COMPONENT C3; MAJOR BASIC PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; THIRD TRIMESTER PREGNANCY;

ANGIOTENSINOGEN; ANIMALS; BIOLOGICAL MARKERS; EOSINOPHIL MAJOR BASIC PROTEIN; FEMALE; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; OXIDATION-REDUCTION; PREGNANCY; PREGNANCY PROTEINS; PROTEIN PRECURSORS; PROTEOGLYCANS;

EID: 84870922969     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120801     Document Type: Article

References (45)

1. Doolittle, R. F. (1983) Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family. Science 222, 417-419
2. Zhou, A., Carrell, R. W., Murphy, M. P., Wei, Z., Yan, Y., Stanley, P. L., Stein, P. E., Broughton Pipkin, F. and Read, R. J. (2010) A redox switch in angiotensinogen modulates angiotensin release. Nature 468, 108-11
3. Irani, R. A. and Xia, Y. (2008) The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta 29, 763-771
4. Gould, A. B. and Green, D. (1971) Kinetics of the human renin and human substrate reaction. Cardiovasc Res. 5, 86-89
5. Slater, E. E. and Strout, Jr, H. V. (1981) Pure human renin. Identification and characterization and of two major molecular weight forms. J. Biol. Chem. 256, 8164-8171 (Pubitemid 12229855)
6. Weir, R. J., Brown, J. J., Fraser, R., Kraszewski, A., Lever, A. F., McIlwaine, G. M., Morton, J. J., Robertson, J. I. and Tree, M. (1973) Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease of pregnancy. Lancet 1, 291-294
7. Gordon, D. B. and Sachin, I. N. (1977) Chromatographic separation of multiple renin substrates in women: effect of pregnancy and oral contraceptives. Proc. Soc. Exp. Biol. Med. 156, 461-464 (Pubitemid 8265228)
8. Tewksbury, D. A. and Dart, R. A. (1982) High molecular weight angiotensinogen levels in hypertensive pregnant women. Hypertension 4, 729-734 (Pubitemid 13239694)
9. Sato, Y., Hiwada, K. and Kokubu, T. (1985) Physicochemical characteristics of human high molecular weight angiotensinogen. Life Sci. 37, 371-377 (Pubitemid 15037036)
10. Tetlow, H. J. and Broughton Pipkin, F. (1986) Changing renin substrates in human pregnancy. J. Endocrinol. 109, 257-262 (Pubitemid 16081657)
11. Tewksbury, D. A. (1996) Quantitation of five forms of high molecular weight angiotensinogen from human placenta. Am. J. Hypertens. 9, 1029-1034
12. Tewksbury, D. A., Goodman, J. R., Kaiser, S. J., Burrill, R. E. and Brown, H. L. (2000) Quantitation of the five forms of plasma high molecular weight angiotensinogen in women with pregnancy-induced hypertension. Am. J. Hypertens. 13, 221-225 (Pubitemid 30206942)
13. Tewksbury, D. A., Tryon, E. S., Burrill, R. E. and Dart, R. A. (1986) High molecular weight angiotensinogen: a pregnancy associated protein. Clin. Chim. Acta 158, 7-12 (Pubitemid 16040091)
14. Campbell, D. J., Bouhnik, J., Coezy, E., Menard, J. and Corvol, P. (1985) Characterization of precursor and secreted forms of human angiotensinogen. J. Clin. Invest. 75, 1880-1893 (Pubitemid 15237797)
15. Tewksbury, D. A. and Tryon, E. S. (1989) Immunochemical comparison of high molecular weight angiotensinogen from amniotic fluid, plasma of men, and plasma of pregnant women. Am. J. Hypertens. 2, 411-413 (Pubitemid 19129837)
16. Stanley, P., Serpell, L. C. and Stein, P. E. (2006) Polymerization of human angiotensinogen: insights into its structural mechanism and functional significance. Biochem. J. 400, 169-178 (Pubitemid 44763832)
17. Oxvig, C., Haaning, J., Kristensen, L., Wagner, J. M., Rubin, I., Stigbrand, T., Gleich, G. J. and Sottrup-Jensen, L. (1995) Identification of angiotensinogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasma. J. Biol. Chem. 270, 13645-13651
18. Christiansen, M., Jaliashvili, I., Overgaard, M. T., Ensinger, C., Obrist, P. and Oxvig, C. (2000) Quantification and characterization of pregnancy-associated complexes of angiotensinogen and the proform of eosinophil major basic protein in serum and amniotic fluid. Clin. Chem. 46, 1099-1105 (Pubitemid 30643311)
19. Bonno, M., Oxvig, C., Kephart, G. M., Wagner, J. M., Kristensen, T., Sottrup-Jensen, L. and Gleich, G. J. (1994) Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab. Invest. 71, 560-566 (Pubitemid 24338164)
20. Overgaard, M. T., Oxvig, C., Christiansen, M., Lawrence, J. B., Conover, C. A., Gleich, G. J., Sottrup-Jensen, L. and Haaning, J. (1999) Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tissues. Biol. Reprod. 61, 1083-1089 (Pubitemid 29455648)
21. Wasmoen, T. L., Coulam, C. B., Leiferman, K. M. and Gleich, G. J. (1987) Increases of plasma eosinophil major basic protein levels late in pregnancy predict onset of labor. Proc. Natl. Acad. Sci. U.S.A. 84, 3029-3032 (Pubitemid 17064771)
22. Oxvig, C., Sand, O., Kristensen, T., Gleich, G. J. and Sottrup-Jensen, L. (1993) Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J. Biol. Chem. 268, 12243-12246 (Pubitemid 23182369)
23. Lawrence, J. B., Oxvig, C., Overgaard, M. T., Sottrup-Jensen, L., Gleich, G. J., Hays, L. G., Yates, III, J. R. and Conover, C. A. (1999) The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc. Natl. Acad. Sci. U.S.A. 96, 3149-3153 (Pubitemid 29148859)
24. Laursen, L. S., Overgaard, M. T., Soe, R., Boldt, H. B., Sottrup-Jensen, L., Giudice, L. C., Conover, C. A. and Oxvig, C. (2001) Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 504, 36-40 (Pubitemid 32777807)
25. Laursen, L. S., Kjaer-Sorensen, K., Andersen, M. H. and Oxvig, C. (2007) Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5 Mol. Endocrinol. 21, 1246-1257 (Pubitemid 46984772)
26. Overgaard, M. T., Glerup, S., Boldt, H. B., Rodacker, V., Olsen, I. M., Christiansen, M., Sottrup-Jensen, L., Giudice, L. C. and Oxvig, C. (2004) Inhibition of proteolysis by the proform of eosinophil major basic protein (proMBP) requires covalent binding to its target proteinase. FEBS Lett. 560, 147-152 (Pubitemid 38264309)
27. Overgaard, M. T., Haaning, J., Boldt, H. B., Olsen, I. M., Laursen, L. S., Christiansen, M., Gleich, G. J., Sottrup-Jensen, L., Conover, C. A. and Oxvig, C. (2000) Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J. Biol. Chem. 275, 31128-31133
28. Rubin, I., Lykkegaard, S., Olsen, A. A., Selmer, J. and Ballegaard, M. (1988) Monoclonal antibodies against human angiotensinogen, their characterization and use in an angiotensinogen enzyme linked immunosorbent assay. J. Immunoassay. 9, 257-274
29. Oxvig, C., Sand, O., Kristensen, T., Kristensen, L. and Sottrup-Jensen, L. (1994) Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Biochim. Biophys. Acta 1201, 415-423 (Pubitemid 24378049)
30. Qin, Q. P., Christiansen, M., Oxvig, C., Pettersson, K., Sottrup-Jensen, L., Koch, C. and Norgaard-Pedersen, B. (1997) Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome. Clin. Chem. 43, 2323-2332 (Pubitemid 28022968)
31. Glerup, S., Kloverpris, S., Laursen, L. S., Dagnaes-Hansen, F., Thiel, S., Conover, C. A. and Oxvig, C. (2007) Cell surface detachment of pregnancy-associated plasma protein-A requires the formation of intermolecular proteinase-inhibitor disulfide bonds and glycosaminoglycan covalently bound to the inhibitor. J. Biol. Chem. 282, 1769-1778 (Pubitemid 47076699)
32. Pear, W. S., Nolan, G. P., Scott, M. L. and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U.S.A. 90, 8392-8396 (Pubitemid 23277674)
33. Glerup, S., Boldt, H. B., Overgaard, M. T., Sottrup-Jensen, L., Giudice, L. C. and Oxvig, C. (2005) Proteinase inhibition by proform of eosinophil major basic protein (pro-MBP) is a multistep process of intra- and intermolecular disulfide rearrangements. J. Biol. Chem. 280, 9823-9832 (Pubitemid 40395828)
34. Gimenez-Roqueplo, A. P., Leconte, I., Cohen, P., Simon, D., Guyene, T. T., Celerier, J., Pau, B., Corvol, P., Clauser, E. and Jeunemaitre, X. (1996) The natural mutation Y248C of human angiotensinogen leads to abnormal glycosylation and altered immunological recognition of the protein. J Biol Chem. 271, 9838-9844 (Pubitemid 26137398)
35. Tewksbury, D. A., Kaiser, S. J. and Burrill, R. E. (2001) A study of the temporal relationship between plasma high molecular weight angiotensinogen and the development of pregnancy-induced hypertension. Am. J. Hypertens. 14, 794-797 (Pubitemid 32682247)
36. Eggena, P., Hidaka, H., Barrett, J. D. and Sambhi, M. P. (1978) Multiple forms of human plasma renin substrate. J. Clin. Invest. 62, 367-372 (Pubitemid 8393306)
37. Young, B. C., Levine, R. J. and Karumanchi, S. A. (2010) Pathogenesis of preeclampsia. Annu. Rev. Pathol. 5, 173-192
38. Gyrup, C., Christiansen, M. and Oxvig, C. (2007) Quantification of proteolytically active pregnancy-associated plasma protein-A with an assay based on quenched fluorescence. Clin. Chem. 53, 947-954 (Pubitemid 46744253)
39. Sahu, A. and Lambris, J. D. (2001) Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 180, 35-48 (Pubitemid 32472850)
40. van Lookeren Campagne, M., Wiesmann, C. and Brown, E. J. (2007) Macrophage complement receptors and pathogen clearance. Cell Microbiol. 9, 2095-2102 (Pubitemid 47250283)
41. Laursen, L. S., Overgaard, M. T., Weyer, K., Boldt, H. B., Ebbesen, P., Christiansen, M., Sottrup-Jensen, L., Giudice, L. C. and Oxvig, C. (2002) Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats. J. Biol. Chem. 277, 47225-47234 (Pubitemid 36159233)
42. Glerup, S., Kloverpris, S. and Oxvig, C. (2006) The proform of the eosinophil major basic protein binds the cell surface through a site distinct from its C-type lectin ligand-binding region. J. Biol. Chem. 281, 31509-31516 (Pubitemid 46041416)
43. Tewksbury, D. A., Pan, N. and Kaiser, S. J. (2003) Detection of a receptor for angiotensinogen on placental cells. Am. J. Hypertens. 16, 59-62 (Pubitemid 36078592)
44. Hogg, P. J. (2003) Disulfide bonds as switches for protein function. Trends Biochem. Sci. 28, 210-214
45. Forbes, K. and Westwood, M. (2008) The IGF axis and placental function. a mini review. Horm. Res. 69, 129-137 (Pubitemid 351161040)